TP53 and neoplasm: The analysis of DNA mutations, including MDM2, TP53, RAS, and FGFR3, is an effective tumor phenotyping tool in defining the molecular subtypes with discrete profiles of gene expression, histology of UUT-UC, and prognostic outcome of patients (73, 76).